UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

Cancer epidemiology, biomarkers & prevention, 2018-06, Vol.27 (6), p.619-626

2018

Volltextzugriff (PDF)

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1305-1315

2019

Volltextzugriff (PDF)

Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer

Cancer, 2018-09, Vol.124 (18), p.3668-3676

2018

Volltextzugriff (PDF)

Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control

Journal of clinical oncology, 2020-05, Vol.38 (13), p.1371-1374

2020

Volltextzugriff (PDF)

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2001-2009

2014

Volltextzugriff (PDF)

Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers

Journal of clinical oncology, 2010-01, Vol.28 (2), p.222-231

2010

Volltextzugriff (PDF)

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

PloS one, 2012-05, Vol.7 (5), p.e33788-e33788

2012

Volltextzugriff (PDF)

Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis

PloS one, 2012-09, Vol.7 (9), p.e43994-e43994

2012

Volltextzugriff (PDF)

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

JAMA oncology, 2015-10, Vol.1 (7), p.943

2015

Volltextzugriff (PDF)

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients

The Journal of molecular diagnostics : JMD, 2015-09, Vol.17 (5), p.533-544

2015

Volltextzugriff (PDF)

Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black―White Crossover

JNCI : Journal of the National Cancer Institute, 2012-07, Vol.104 (14), p.1094-1101

2012

Volltextzugriff (PDF)

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

Clinical cancer research, 2018-06, Vol.24 (12), p.2851-2858

2018

Volltextzugriff (PDF)

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

Breast cancer research : BCR, 2010-11, Vol.12 (6), p.R99-R99, Article R99

2010

Volltextzugriff (PDF)

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

JAMA oncology, 2018-08, Vol.4 (8), p.1066

2018

Volltextzugriff (PDF)

Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study

Breast cancer research : BCR, 2024-05, Vol.26 (1), p.88-29, Article 88

2024

Volltextzugriff (PDF)

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics

Cancer medicine (Malden, MA), 2022-01, Vol.11 (2), p.297-307

2022

Volltextzugriff (PDF)

The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study

BMC cancer, 2024-08, Vol.24 (1), p.1-11, Article 975

2024

Volltextzugriff (PDF)

Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups

JAMA oncology, 2023-04, Vol.9 (4), p.473

2023

Volltextzugriff (PDF)

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer

Nature communications, 2023-04, Vol.14 (1), p.2053-2053, Article 2053

2023

Volltextzugriff (PDF)

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

British journal of cancer, 2016-06, Vol.115 (1), p.129-135

2016

Volltextzugriff (PDF)

Weakly supervised temporal model for prediction of breast cancer distant recurrence

Scientific reports, 2021-05, Vol.11 (1), p.9461-9461, Article 9461

2021

Volltextzugriff (PDF)

Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women

JCO precision oncology, 2017-11 (1), p.1-12

2017

Volltextzugriff (PDF)

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.471-478

2011

Volltextzugriff (PDF)

Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers

Journal of clinical oncology, 2012-02, Vol.30 (5), p.497-506

2012

Volltextzugriff (PDF)

Recurrent BRCA2 exon 3 deletion in Assyrian families

Journal of medical genetics, 2024-02, Vol.61 (2), p.155-157

2024

Volltextzugriff (PDF)

1 – 25 von 388

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(381)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients

Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer

Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients

Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black―White Crossover

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics

The population-level effects of omitting chemotherapy guided by a 21-gene expression assay in node-positive breast cancer: a simulation modeling study

Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer

Statin use and all-cancer survival: prospective results from the Women's Health Initiative

Weakly supervised temporal model for prediction of breast cancer distant recurrence

Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers

Recurrent BRCA2 exon 3 deletion in Assyrian families

Suchergebnisse filtern